INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$382K
8,731 sh
Feb 9, 2026
Page 396 of 550
← PrevNext →
Feb 11, 2026
traded Feb 9, 2026
+2d
SEC Form 4

Evidence

15
SW
Shattuck Katherine WDirector
CZNCCITIZENS & NORTHERN CORP
Open-market purchase · 10b5-1 plan
BUY$372
16 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

15
RM
Ragosa MarkCHIEF FINANCIAL OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$391K
9,114 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$4,210
24 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
177 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$5,445
32 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

13
WF
Widman FredrikVP Corporate Controller
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$66K
133 sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

13
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
190 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$405K
521 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$438K
563 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

11
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$304K
391 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

9
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$718K
47.2K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

8
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$161K
16.2K sh
Feb 11, 2026Feb 11, 2026
traded Feb 11, 2026
+0dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$160K
205 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,171 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$113K
144 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

4
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$59K
75 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

3
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
2,756 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
DK
DeHoff KateSee Remarks
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
1,076 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$16K
20 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
2,500 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$29K
37 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$42K
53 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$20K
26 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

1
PJ
Pitofsky JasonSVP Controller
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$785
1 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

59
SA
Sacks Anelise AngelinoDirector
RALRalliant Corp
Open-market purchase
BUY$83K
2,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

44
GC
Gantt Greg CDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Open-market sale
SELL$2.36M
12.0K sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

43
CC
Canuso Dominic CEVP & Chief Financial Officer
TBBKBancorp, Inc.
Open-market purchase
BUY$50K
800 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

43
HH
Hussain HamidPRESIDENT OF THE BANK
BANCBANC OF CALIFORNIA, INC.
Open-market purchase
BUY$296K
14.0K sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

42
CC
Canuso Dominic CEVP & Chief Financial Officer
TBBKBancorp, Inc.
Open-market purchase
BUY$121K
2,000 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

39
CC
Canuso Dominic CEVP & Chief Financial Officer
TBBKBancorp, Inc.
Open-market purchase
BUY$12K
200 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

35
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Open-market sale
SELL$541K
5,118 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

31
MJ
Mills Desmond JSVP & Chief Accounting Officer
WFRDWeatherford International plc
Open-market sale
SELL$521K
5,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

21
WA
Wilson John J. AddingtonCHIEF OPERATING OFFICER
RPIDRAPID MICRO BIOSYSTEMS, INC.
Open-market sale
SELL$17K
4,610 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

12
SS
Smith Brian ScottPresident, Hearth & Home Tech
HNIHNI CORP
Open-market sale · 10b5-1 plan
SELL$104K
2,000 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

12
FD
Feierstein Matthew DavidPresident
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$54K
5,000 sh
Feb 5, 2026Feb 10, 2026
traded Feb 5, 2026
+5dSEC Form 4

Evidence

10
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$58K
2,056 sh
Feb 10, 2026Feb 10, 2026
traded Feb 10, 2026
+0dSEC Form 4

Evidence

8
VV
Vultaggio VincentPAO and PFO
ZNTLZentalis Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
30.0K sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence

8
SN
Schmitt Thomas NCPO, Skyward Group
SKWDSkyward Specialty Insurance Group, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
2,616 sh
Feb 9, 2026Feb 10, 2026
traded Feb 9, 2026
+1dSEC Form 4

Evidence

4
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
1,836 sh
Feb 6, 2026Feb 10, 2026
traded Feb 6, 2026
+4dSEC Form 4

Evidence